These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Making clinical trials safer for human subjects. Baram M Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112 [No Abstract] [Full Text] [Related]
13. The IRB is not a data and safety monitoring board. Bankert E; Amdur R IRB; 2000; 22(6):9-11. PubMed ID: 11883486 [No Abstract] [Full Text] [Related]
14. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives]. Englev E; Petersen KP Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823 [TBL] [Abstract][Full Text] [Related]
15. Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity. Sartor O Oncologist; 2018 Jan; 23(1):1. PubMed ID: 29158364 [TBL] [Abstract][Full Text] [Related]
16. New software to facilitate clinical trials safety reporting. J Support Oncol; 2004; 2(5):432-3. PubMed ID: 15524072 [No Abstract] [Full Text] [Related]
17. Four initiatives proposed to improve safety reporting in clinical trials. J Support Oncol; 2004; 2(5):431-2. PubMed ID: 15524071 [No Abstract] [Full Text] [Related]
18. Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index. Welch V; Singh G; Strand V; Fries J; Boers M; Ramey D; Day RO; Brooks P; Tugwell P; Clinch J; Kristjansson B J Rheumatol; 2001 May; 28(5):1188-91. PubMed ID: 11361211 [TBL] [Abstract][Full Text] [Related]